Decio L. Eizirik, Priscila L. Zimath. Diabetes research enters the biobank era: searching for the truth in a deep well. The Journal of Clinical Investigation. 2025;135(23):e199728. doi:10.1172/JCI199728
Jessica Cait, Alissa Cait, R. Wilder Scott, Charlotte B. Winder, Georgia J. Mason. Conventional laboratory housing increases morbidity and mortality in research rodents: results of a meta-analysis. BMC Biology. 2022;20(1):15. doi:10.1186/s12915-021-01184-0
Angela Russo, Zizhao Yang, Georgette Moyle Heyrman, et al. Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer. Cancer Letters. 2022;543:215779. doi:10.1016/j.canlet.2022.215779
Jean S. McGee, Curtis Huttenhower. Of mice and men and women: Sexual dimorphism of the gut microbiome. International Journal of Women’s Dermatology. 2021;7(5, Part A):533-538. doi:10.1016/j.ijwd.2021.10.007
Jennifer M. McCracken, Gisele A. Calderon, Andrew J. Robinson, Courtney N. Sullivan, Elizabeth Cosgriff-Hernandez, Julie C. E. Hakim. Animal Models and Alternatives in Vaginal Research: a Comparative Review. Reproductive Sciences. 2021;28(6):1759-1773. doi:10.1007/s43032-021-00529-y
Rasa Elmentaite, Natsuhiko Kumasaka, Kenny Roberts, et al. Cells of the human intestinal tract mapped across space and time. Nature. 2021;597(7875):250-255. doi:10.1038/s41586-021-03852-1
Tomasz Kostrzewski, Sophie Snow, Anya Lindström Battle, et al. Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system. Communications Biology. 2021;4(1):1080. doi:10.1038/s42003-021-02616-x
Yuling Han, Xiaohua Duan, Liuliu Yang, et al. Identification of SARS-CoV-2 inhibitors using lung and colonic organoids. Nature. 2021;589(7841):270-275. doi:10.1038/s41586-020-2901-9
Jens Puschhof, Cayetano Pleguezuelos-Manzano, Hans Clevers. Organoids and organs-on-chips: Insights into human gut-microbe interactions. Cell Host & Microbe. 2021;29(6):867-878. doi:10.1016/j.chom.2021.04.002
Vanessa Monteil, Hyesoo Kwon, Patricia Prado, et al. Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2. Cell. 2020;181(4):905-913.e7. doi:10.1016/j.cell.2020.04.004